For a condition that affects 10 to 15% of women worldwide, endometriosis research, like most of research about women’s health ...

Healthcare company Organon & Co. (OGN) said on Wednesday that it is discontinuing the development of its investigational ...

The women’s health focused company acquired the drug for up to $954 million in 2021 through the acquisition of Forendo Pharma ...

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

Around one in ten women worldwide has endometriosis, but researchers still aren’t entirely sure what triggers it ...

Organon said on Wednesday it will discontinue the development of its experimental drug, after it failed to reduce pain in women suffering from endometriosis in a mid-stage study.

"I’ll always have a chronic disease, but I will not let it define me—it’s just one part of my story." ...

The aging American population contributes to rising cancer rates across all demographics, but additional factors amplify ...

New research links endometriosis to autoimmune diseases, revealing shared mechanisms that may lead to earlier diagnosis and ...

A low FODMAP diet developed by Monash University researchers for irritable bowel syndrome (IBS) has been shown to improve ...